- BreathID Hp
- Events & Webinars
- Patient Information
The following CPT* codes may describe the procedure performed:
83013: Helicobacter pylori; breath test analysis for urease activity, non-radioactive isotope (e.g., C-13)
83014: Helicobacter pylori; drug administration
The latest Medicare Clinical Laboratory Fee Schedule, with a state-by-state fee schedule, can be downloaded from http://www.cms.hhs.gov/ClinicalLabFeesched/02_clinlab.asp
* The use of these codes does not guarantee payment.
Use of the CPT Codes 83013 and 83014 can vary depending on site of service considerations, as well as state law, which may regulate the provision and billing of diagnostic and clinical lab tests, and insurance carriers. It is the physician's and lab's responsibility to submit claims in full compliance with insurer requirements and state/federal law.
Exalenz assumes no responsibility for the consequences related to the use of information above. All codes presented in this document are for informational purposes only. Healthcare providers must follow specific insurers' coding and billing instructions and must report the codes that most accurately reflect the patient's condition and the medically necessary
service(s) provided. The information above does not constitute legal advice.
All five-digit numeric CPT codes, descriptions, instructions and guidelines are Copyright 2009 of the American Medical Association.
In the USA, the BreathID System is intended for use in the qualitative detection of H. pylori. It has FDA 510(k) clearance and an approved NDA for the 13C-urea tablet and citrica powder. Other applications are limited in the U.S. by U.S. federal law to Investigational Use only. In Europe, the BreathID and BreathID Hp devices have CE approval for diagnostic monitoring of the digestive system and liver.
Exalenz provides its services and information for your convenience only and does not intend them as a recommendation regarding clinical practice, as any representation or warranty regarding payment or as a guarantee of payment by any payer. It is the responsibility of the provider to ensure that appropriate claims and charges for services that were rendered are submitted. In the event coverage is denied, Exalenz is not and shall not be liable for the cost of the patient’s medical treatment.
For more information please visit the Centers for Medicare & Medicaid Services.